Volume 37, Issue 4 pp. 1448-1457
ORIGINAL CLINICAL ARTICLE

Medication use and association with urinary incontinence in women: Data from the Norwegian Prescription Database and the HUNT study

Siri A. Mauseth MD

Corresponding Author

Siri A. Mauseth MD

Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Correspondence

Siri A. Mauseth, MD, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Email: [email protected]

Search for more papers by this author
Svetlana Skurtveit PhD

Svetlana Skurtveit PhD

Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway

Search for more papers by this author
Eva Skovlund PhD

Eva Skovlund PhD

Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway

Faculty of Medicine and Health Sciences, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway

Search for more papers by this author
Arnulf Langhammer PhD

Arnulf Langhammer PhD

Faculty of Medicine and Health Sciences, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway

Search for more papers by this author
Olav Spigset PhD

Olav Spigset PhD

Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway

Search for more papers by this author
First published: 16 January 2018
Citations: 4
Hashim Hashim led the peer-review process as the Associate Editor responsible for the paper.

Abstract

Aims

To investigate the association between medication use and urinary incontinence (UI) in women.

Methods

In a cross-sectional population-based study we analyzed questionnaire data on UI, including type and severity, from 21 735 women included in the Nord-Trøndelag Health Study (HUNT) in Norway. These data were linked to data on filled prescriptions retrieved from the Norwegian Prescription Database. A multivariate logistic regression model was used to calculate the odds for having UI related to the number of filled prescriptions for selected drug groups during the 6 months prior to participation in HUNT, after adjustment for numerous confounding factors.

Results

Significant associations with UI were found for selective serotonin reuptake inhibitors (SSRIs) and lamotrigine with OR 1.52 (1.30-1.78) and 2.73 (1.59-4.68) for two or more filled prescriptions. Both for SSRIs and lamotrigine, the associations were pronounced for mixed UI, whereas there were no clear-cut increased risk of stress UI and urgency UI. The relations were strongest in women with the most severe symptoms. One filled prescription of antipsychotics, but not two or more, was also found to be related to UI with OR 1.91 (1.35-2.71). No associations were found for benzodiazepines, zopiclone/zolpidem, beta blockers, and diuretics.

Conclusions

The odds for having UI were found to be about 1.5-fold in women using SSRIs and almost threefold in women using lamotrigine. The association with lamotrigine has not been reported previously, and should be further evaluated in future studies.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.